Chronic Liver Diseases and COVID-19: Database of General Hospital

QR Code

Chronic Liver Diseases and COVID-19: Database of General Hospital

Patients with chronic liver diseases (CLD) are at high risk of infection and severe COVID-19 (Corona Virus Disease).Aim: to create a database of patients with CLD, including an analysis of the frequency of detection of SARS-CoV-2 markers, the causes of hospitalization, an assessment of 30-day mortal...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. Yu. Sitnikova, L. Yu. Ilchenko, I. G. Fedorov, I. G. Nikitin
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2023-01-01
Series:	Архивъ внутренней медицины
Subjects:	covid-19 chronic liver disease database mortality alcoholic liver disease
Online Access:	https://www.medarhive.ru/jour/article/view/1562
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

COVID-19 and Liver Damage
by: L. Yu. Ilchenko, et al.
Published: (2020-05-01)

Real-World Clinical and Economic Efficacy of Succinate-Based Therapy with Remaxol of Alcohol Hepatitis
by: L. Yu. Il’chenko, et al.
Published: (2024-02-01)

PATOMORFOLOGICHESKY ASSESSMENT ETHANOL POISONING AMID ALCOHOLIC LIVER DISEASE
by: E. N. Travenko, et al.
Published: (2017-07-01)

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program)
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Mechanisms of copper metabolism and cuproptosis: implications for liver diseases
by: Haoran Chen, et al.
Published: (2025-07-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Dynamics of registered alcohol-attributable mortality in Krasnodar Krai
by: A. N. Redko, et al.
Published: (2020-08-01)

High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease
by: Tung-Hung Su, et al.
Published: (2025-07-01)

Efficacy of silymarinum at chronic diffuse liver diseases
by: A. V. Matvieiev, et al.
Published: (2011-09-01)

Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States
by: Pojsakorn Danpanichkul, et al.
Published: (2025-07-01)

Nonalcoholic Fatty Liver Disease in Patients with Normal Body Weight: Epidemiology, Current Issues of Screening and Diagnosis, Approaches to Therapy
by: I. G. Nikitin, et al.
Published: (2025-07-01)

Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease
by: I. I. Vakalyuk, et al.
Published: (2018-03-01)

Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
by: Xianhua Mao, et al.
Published: (2025-07-01)

The Course of Alcoholic Cirrhosis of The Liver in a Patient with COVID-19
by: E. Y. Kudashkina, et al.
Published: (2022-05-01)

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
by: N. V. Mikhaylova, et al.
Published: (2019-07-01)

Lipidomic analysis of alcohol use disorder patients revealed the biomarkers for alcohol-related liver disease susceptibility
by: Dongyao Wang, et al.
Published: (2025-07-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

Improvement of liver fibrosis verification using new minimally invasive markers in patients with chronic diffuse liver diseases
by: Yu.M. Stepanov, et al.
Published: (2022-12-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
by: S. E. Evstifeeva, et al.
Published: (2022-10-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)

Non-alcoholic fatty liver disease and metabolic liver dysfunction in the new coronavirus infection COVID-19
by: A. A. Karaseva, et al.
Published: (2021-12-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Regional variations and trends in liver transplantation practices across Europe
by: Tommaso Di Maira, et al.
Published: (2025-08-01)

Non-alcoholic fatty liver disease as a risk factor for anemia of chronic inflammation (experimental research)
by: T. V. Brus, et al.
Published: (2023-07-01)

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
by: V. T. Ivashkin, et al.
Published: (2022-12-01)

Trends in Liver Cirrhosis and Diabetes-Related Mortality Among Adults in the United States: A CDC WONDER Database Analysis (1999–2020)
by: Manahil Irfan, et al.
Published: (2025-05-01)

Hydrophilic and lipophilic statin and clinical outcomes in individuals with alcohol-associated liver disease
by: Pojsakorn Danpanichkul, et al.
Published: (2025-07-01)

Modern Possibilities of Endosurgical Biopsy in Children with Chronic Liver Diseases
by: Polina V. Khrolenko, et al.
Published: (2018-07-01)

Comparison of Transient Elastography and Liver Biopsy in Assessing Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Gaurav Bachhav, et al.
Published: (2021-05-01)

Hyperparathyroidism in Patients with End-Stage Chronic Liver Disease (Clinical Observations)
by: A. A. Lavreniuk, et al.
Published: (2024-12-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

CORRECTION OF MICROCIRCULATORY DISORDERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHRONIC HEART FAILURE PATIENTS
by: M. E. Statsenko, et al.
Published: (2016-12-01)

Hepatogenic weakness as a clinical marker of hyperammonemia and of the effectiveness of its correction in patients with pre-cirrhotic stages of non-alcoholic fatty liver disease
by: E. M. Petrova, et al.
Published: (2021-06-01)

Modern Possibilities of Liver Diffusion-Weighted Magnetic Resonance Images in the Diagnosis of Alcoholic Liver Disease
by: F. S. Lozbenev, et al.
Published: (2022-10-01)

What is new in the 2024 Chinese guidelines for fatty liver disease?
by: Rui-Xu Yang, et al.
Published: (2025-07-01)